Navigation Links
Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
Date:4/11/2013

gnancies, including chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, Waldenström's macroglobulinemia and multiple myeloma. To date five Phase III trials have been initiated with ibrutinib and a total of 26 trials are currently registered on www.clinicaltrials.gov.

About Pharmacyclics
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The Company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.  

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including stat
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
2. Pharmacyclics, Inc. Prices Public Offering of Common Stock
3. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
4. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
5. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
6. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
7. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. New survey finds women who suffer from migraines want a better understanding of migraine triggers
10. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
11. Cardinal Health Foundation, The Ohio State University Launch Fourth Toolkit to Help Reduce Abuse of Prescription Drugs on College Campuses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015  Regulatory leaders in the pharmaceutical ... discussion draft called "21 st Century Cures." ... be taken up by Congress soon and if enacted ... device products are developed and marketed in ... companies have begun to consider how the proposed changes ...
(Date:4/17/2015)... -- Inivata, a Cambridge, England ... at the 2015 American Association for Cancer Research (AACR) Annual ... Rosenfeld and a poster presentation. Michael Stocum , ... 22 nd . The presentation, entitled Monitoring ... forms part of a session on Recent Advances in ...
(Date:4/17/2015)... ASSESS shows   plasma circulating tumour DNA (ctDNA) ... tumour biopsy   IGNITE supports value of ... AstraZeneca today presented results from two key studies ... for epidermal growth factor receptor (EGFR) mutation status in newly ... clinical practice. [ 1 ] , ...
Breaking Medicine Technology:21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... Oct. 20 HealthLeaders-InterStudy, a leading provider of managed ... San Diego area are looking to secure a strong ... of commercial and Medicare reimbursements by developing and growing ... will limit physician access for pharmaceutical reps. According to ...
... world renowned heart center has expanded and enhanced its ... Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak. ... offer breakthrough surgeries and treatments for people with high-risk ... new home for Beaumont,s innovative "7 tests for $70" ...
Cached Medicine Technology:The Development of Medical Foundations in the San Diego Area will Restrict Physician Access for Pharmaceutical Reps 2Beaumont Hospital Opens New Ernst Cardiovascular Center 2
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant ... Week Celebration on April 20 with a day full ... body and soul. , The community, which is located ... adults of all incomes, including those on Medicaid, who ... Living Week is observed every April and highlights the ...
(Date:4/17/2015)... Oklahoma (PRWEB) April 17, 2015 Alcohol ... Drug Dependence (NCADD) notes that drinking and driving has ... At the same time, the link between alcohol ... as domestic abuse and violence and sexual assault, and ... According to the NCADD, 5.3 million adults in America ...
(Date:4/17/2015)... Consumers who prefer to have a standard ... use the Insurance Pros USA website for web research. ... are featured by leading companies quoting plans at ... are mixed between three of the most popular coverage ... now term, universal and whole policies that are quoted ...
(Date:4/17/2015)... Most dental patients are not aware that ... overseas by foreign dental laboratories, according to the U.S. ... more than 40 states by their respective state boards ... Laboratories has created the “What’s In Your ... the consequences that could be associated with using poorly-made ...
(Date:4/17/2015)... The American College of Traditional Chinese Medicine (ACTCM) is ... April 29. The event will be held from 11 a.m. to ... St. in San Francisco, CA. , The agenda for the day ... DeHaro campus (room F), 11:10 a.m. – Introduction and welcome ... lunch with current students, faculty and staff, 1 p.m. – Observe ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:National Association Urges Transparency in Dental Industry 2Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... ... ... -- CMS Watch announced today that it has changed its name to The Real ... , , ,“The new name better reflects what we,ve been doing for nearly a decade: ...
... , ... ... ... ...
... , ... ... ... ...
... of certain proteins in premalignant oral lesions may ... researchers said. SIBLINGs, or Small Integrin-Binding Ligand ... that help mineralize bone but can also spread ... breast, lung, colon and prostate. "Several years ...
... 10-15 years. After this time, the operation has to be ... as, in general, it is elderly people that use the ... Donostia-San Sebastin, has just published her PhD, a thesis which ... According to Ms Garmendia, using a ceramic material called zirconia ...
... ... presented at WebInno25 , ... New York, NY (PRWEB) February 23, 2010 -- Vizibility Inc. ( www.vizibility.com ... branding service for career professionals at Web Innovators Group (aka WebInno) in Boston. Hosted ...
Cached Medicine News:Health News:CMS Watch Changes Name to The Real Story Group 2Health News:CMS Watch Changes Name to The Real Story Group 3Health News:Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2Health News:Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3Health News:Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4Health News:Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5Health News:Diabetics Twice as Likely to Have Hearing Loss; Florida HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 6Health News:Global Hospitals and Healthcare Suppliers Focus on Cutting Costs and Improving Quality at 2010 GHX Supply Chain Summit 2Health News:Global Hospitals and Healthcare Suppliers Focus on Cutting Costs and Improving Quality at 2010 GHX Supply Chain Summit 3Health News:Global Hospitals and Healthcare Suppliers Focus on Cutting Costs and Improving Quality at 2010 GHX Supply Chain Summit 4Health News:Global Hospitals and Healthcare Suppliers Focus on Cutting Costs and Improving Quality at 2010 GHX Supply Chain Summit 5Health News:SIBLING proteins may predict oral cancer 2Health News:Material tested that could guarantee body protheses for more than 150 years 2Health News:Vizibility A Side Dish At Web Innovators Group Event 2Health News:Vizibility A Side Dish At Web Innovators Group Event 3
... Sonys new DFW-SX910 digital camera is equipped ... with square pixels and offers excellent sensitivity ... This camera delivers uncompressed, high-resolution, ... asynchronous electronic shutter function with an exposure ...
... The PL-A662 is PixeLINKs most popular microscopy ... 1.3 Megapixel FireWire camera suitable for use ... PixeLINKs most popular microscopy camera. Desgined to ... image acquisition, the PL-A662 provides uncompromising video ...
... Gene Tech acclaimed GT-CAPTURE digital camera photomicrographic ... manufacturers microscope such as Olympus, Leica, Nikon, ... base and transferring images over the Internet ... CCD and a performance-proven Nikkor lens. The ...
... Carl Zeiss developed for ... expert. Not only does it ... all image formats, it is ... with the microscope and fully ...
Medicine Products: